Literature DB >> 18549320

Mesenchymal cells for skeletal tissue engineering.

Bethany J Slater1, Matthew D Kwan, Deepak M Gupta, Nicholas J Panetta, Michael T Longaker.   

Abstract

BACKGROUND: Skeletal defects represent a significant socioeconomic burden to the US healthcare system. Current options for reconstructing osseous deficits have shortcomings.
OBJECTIVE: To review the use of mesenchymal stem cells for skeletal tissue engineering.
METHODS: We focused on the application of mesenchymal cells in skeletal regeneration, optimization of this technique, tropic effects of multipotent mesenchymal cells, and future directions. RESULTS/
CONCLUSION: A number of cell-based modalities have been investigated. We have been interested in the role of adipose-derived stromal cells in bone regeneration and understanding the mechanisms behind osteogenic differentiation of progenitor cells and acceleration of this process. Future clinical applications of multipotent mesenchymal cells will depend on better understanding of the molecular signaling involved in osteogenic differentiation and maintaining pluripotency.

Entities:  

Mesh:

Year:  2008        PMID: 18549320     DOI: 10.1517/14712598.8.7.885

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  11 in total

1.  Stem cell-based bone repair.

Authors:  Yurong Fei; Ren-He Xu; Marja M Hurley
Journal:  Am J Stem Cells       Date:  2012-05-18

2.  Effects of FGF2 and FGF9 on osteogenic differentiation of bone marrow-derived progenitors.

Authors:  T Kizhner; D Ben-David; E Rom; A Yayon; E Livne
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-02-27       Impact factor: 2.416

3.  The modulation of Th2 immune pathway in the immunosuppressive effect of human umbilical cord mesenchymal stem cells in a murine asthmatic model.

Authors:  Chin-Kan Chan; Ting-Chun Lin; Yung-An Huang; Ya-Shan Chen; Chia-Ling Wu; Huei-Yu Lo; Ming-Ling Kuo; Kang-Hsi Wu; Jing-Long Huang
Journal:  Inflamm Res       Date:  2016-07-06       Impact factor: 4.575

4.  Lipid nanoparticle-mediated silencing of osteogenic suppressor GNAS leads to osteogenic differentiation of mesenchymal stem cells in vivo.

Authors:  Genc Basha; Andrew G Cottle; Thavaneetharajah Pretheeban; Karen Yt Chan; Dominik Witzigmann; Robert N Young; Fabio Mv Rossi; Pieter R Cullis
Journal:  Mol Ther       Date:  2022-06-22       Impact factor: 12.910

5.  Osteogenic differentiation of mesenchymal stem cells promoted by overexpression of connective tissue growth factor.

Authors:  Jin-jing Wang; Feng Ye; Li-jia Cheng; Yu-jun Shi; Ji Bao; Huai-qiang Sun; Wei Wang; Peng Zhang; Hong Bu
Journal:  J Zhejiang Univ Sci B       Date:  2009-05       Impact factor: 3.066

6.  Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials.

Authors:  Deana S Shenaq; Farbod Rastegar; Djuro Petkovic; Bing-Qiang Zhang; Bai-Cheng He; Liang Chen; Guo-Wei Zuo; Qing Luo; Qiong Shi; Eric R Wagner; Enyi Huang; Yanhong Gao; Jian-Li Gao; Stephanie H Kim; Ke Yang; Yang Bi; Yuxi Su; Gaohui Zhu; Jinyong Luo; Xiaoji Luo; Jiaqiang Qin; Russell R Reid; Hue H Luu; Rex C Haydon; Tong-Chuan He
Journal:  Stem Cells Int       Date:  2010-12-16       Impact factor: 5.443

7.  Polymeric implant materials for the reconstruction of tracheal and pharyngeal mucosal defects in head and neck surgery.

Authors:  Dorothee Rickert
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-03-10

Review 8.  Stem cell applications in military medicine.

Authors:  Gregory T Christopherson; Leon J Nesti
Journal:  Stem Cell Res Ther       Date:  2011-10-19       Impact factor: 6.832

Review 9.  Once fat was fat and that was that: our changing perspectives on adipose tissue.

Authors:  W F Ferris; N J Crowther
Journal:  Cardiovasc J Afr       Date:  2011 May-Jun       Impact factor: 1.167

10.  The cannabinoid receptor type 1 is essential for mesenchymal stem cell survival and differentiation: implications for bone health.

Authors:  Aoife Gowran; Katey McKayed; Veronica A Campbell
Journal:  Stem Cells Int       Date:  2013-06-24       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.